Image of Jennifer J. Furin

Jennifer J. Furin, M.D., Ph.D.

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
Authors: Authors: Furin J, Brigden G, Lessem E, Rich M, Vaughan L, Lynch S.
Emerg Infect Dis
View full abstract on Pubmed
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
Authors: Authors: Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P.
Int J Tuberc Lung Dis
View full abstract on Pubmed
The tuberculosis emergency in eastern Europe.
Authors: Authors: Furin J, Isaakidis P.
Lancet HIV
View full abstract on Pubmed
Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru.
Authors: Authors: Tierney DB, Milstein MB, Manjourides J, Furin JJ, Mitnick CD.
Glob Pediatr Health
View full abstract on Pubmed
Peripheral neuropathy in persons with tuberculosis.
Authors: Authors: Mafukidze AT, Calnan M, Furin J.
J Clin Tuberc Other Mycobact Dis
View full abstract on Pubmed
No one with HIV should die from tuberculosis.
Authors: Authors: Furin J, Akugizibwe P, Ditiu L, Gray G, Palmero D, Zaidi S.
Lancet
View full abstract on Pubmed
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
Authors: Authors: Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
Authors: Authors: Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK.
Int J Tuberc Lung Dis
View full abstract on Pubmed
A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
Authors: Authors: Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ.
Int J Tuberc Lung Dis
View full abstract on Pubmed
A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
Authors: Authors: Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ.
Int J Tuberc Lung Dis
View full abstract on Pubmed